These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 20560909

  • 1. Prolonged protection of the new inhaled corticosteroid fluticasone furoate against AMP hyperresponsiveness in patients with asthma.
    van den Berge M, Luijk B, Bareille P, Dallow N, Postma DS, Lammers JW.
    Allergy; 2010 Dec; 65(12):1531-5. PubMed ID: 20560909
    [Abstract] [Full Text] [Related]

  • 2. Duration of effect of single-dose inhaled fluticasone propionate on AMP-induced bronchoconstriction.
    Luijk B, Kempsford RD, Wright AM, Zanen P, Lammers JW.
    Eur Respir J; 2004 Apr; 23(4):559-64. PubMed ID: 15083754
    [Abstract] [Full Text] [Related]

  • 3. Addition of fexofenadine to inhaled corticosteroid therapy to reduce inflammatory biomarkers in atopic asthma.
    Fardon TC, Lee DK, Hodge MR, Lipworth BJ.
    Ann Allergy Asthma Immunol; 2005 Sep; 95(3):259-65. PubMed ID: 16200817
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Airway responsiveness to adenosine after a single dose of fluticasone propionate discriminates asthma from COPD.
    Spicuzza L, Scuderi V, Morjaria JB, Prosperini G, Arcidiacono G, Caruso M, Folisi C, Di Maria GU, Polosa R.
    Pulm Pharmacol Ther; 2014 Feb; 27(1):70-5. PubMed ID: 23688422
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dose-related response to inhaled fluticasone propionate in patients with methacholine-induced bronchial hyperresponsiveness: a double-blind, placebo-controlled study.
    Noonan MJ, Chervinsky P, Wolfe J, Liddle R, Kellerman DJ, Crescenzi KL.
    J Asthma; 1998 Feb; 35(2):153-64. PubMed ID: 9576141
    [Abstract] [Full Text] [Related]

  • 8. Effect of inhaled steroid therapy on exhaled nitric oxide and bronchial responsiveness in children with asthma.
    Nishio K, Odajima H, Motomura C, Nakao F, Nishima S.
    J Asthma; 2006 Dec; 43(10):739-43. PubMed ID: 17169825
    [Abstract] [Full Text] [Related]

  • 9. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
    Koenig SM, Murray JJ, Wolfe J, Andersen L, Yancey S, Prillaman B, Stauffer J, Dorinsky P.
    Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683
    [Abstract] [Full Text] [Related]

  • 10. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma.
    Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR.
    N Engl J Med; 2005 May 26; 352(21):2163-73. PubMed ID: 15914548
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: results from the DIMCA programme.
    den Otter JJ, van Schayck CP, Folgering HT, van den Boom G, Akkermans RP, van Weel C.
    Eur J Gen Pract; 2007 May 26; 13(2):89-91. PubMed ID: 17534745
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Association of symptom control with changes in lung function, bronchial hyperresponsiveness, and exhaled nitric oxide after inhaled corticosteroid treatment in children with asthma.
    Park GM, Han HW, Kim JY, Lee E, Cho HJ, Yoon J, Hong SJ, Yang SI, Yang HJ, Yu J.
    Allergol Int; 2016 Oct 26; 65(4):439-443. PubMed ID: 27160342
    [Abstract] [Full Text] [Related]

  • 15. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma.
    Fritscher LG, Rodrigues MT, Zamel N, Chapman KR.
    Respir Med; 2009 Feb 26; 103(2):296-300. PubMed ID: 18805684
    [Abstract] [Full Text] [Related]

  • 16. Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma.
    Koopmans JG, Lutter R, Jansen HM, van der Zee JS.
    Thorax; 2006 Apr 26; 61(4):306-12. PubMed ID: 16449264
    [Abstract] [Full Text] [Related]

  • 17. Protective effect on AMP airway responsiveness after a single dose of fluticasone.
    Spicuzza L, Di Maria G, Polosa R.
    Eur Respir J; 2004 Oct 26; 24(4):711-2. PubMed ID: 15459157
    [No Abstract] [Full Text] [Related]

  • 18. Monitoring asthma therapy using indirect bronchial provocation tests.
    Brannan JD, Koskela H, Anderson SD.
    Clin Respir J; 2007 Jul 26; 1(1):3-15. PubMed ID: 20298272
    [Abstract] [Full Text] [Related]

  • 19. One-year treatment with different dosing schedules of fluticasone propionate in childhood asthma. Effects on hyperresponsiveness, lung function, and height.
    Visser MJ, Postma DS, Arends LR, de Vries TW, Duiverman EJ, Brand PL.
    Am J Respir Crit Care Med; 2001 Dec 01; 164(11):2073-7. PubMed ID: 11739137
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.